Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Wearing a cap doesn't affect quality of life for Indian men with hair loss, but severe hair loss does lower it. Older men have more severe hair loss, and those who wear caps more often want less treatment.

Upadacitinib effectively treats severe alopecia areata and is safe.

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

Iron deficiency is linked to hair loss in adolescents, especially females, in northern Sudan.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Baricitinib is an effective treatment for severe alopecia areata.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Stress can worsen skin conditions by affecting hormone levels and immune response.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

EGFR inhibitors for lung cancer can cause severe skin issues.